M&A Deal Summary

Vitrolife Acquires Efertility

On May 2, 2024, Vitrolife acquired software company Efertility

Acquisition Highlights
  • This is Vitrolife’s 1st transaction in the Software sector.
  • This is Vitrolife’s 1st transaction in the Netherlands.

M&A Deal Summary
Date 2024-05-02
Target Efertility
Sector Software
Buyer(s) Vitrolife
Deal Type Add-on Acquisition

Target

Efertility

IJsselstein, Netherlands
website
Efertility is an innovative system and software company transforming IVF clinic management with its cutting-edge solutions. Efertility is based in IJsselstein, Netherlands.

Search 193,711 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Vitrolife

Goteborg, Sweden

website

Category Company
Founded 1994
Sector Life Science
Employees424
Revenue 1.2B SEK (2020)
DESCRIPTION

Vitrolife is a producer and developer of products and systems for assisted reproduction worldwide. It offers fertility products, including follicle aspiration needles, paraffin oil under the OVOIL brand, additional media for in vitro fertilization (IVF) procedures, labware products, vitrification products, and Primo Vision time-lapse embryo monitoring systems. Vitrolife was founded in 1994 and is based in Gothenburg, Sweden.

DEAL STATS #
Overall 7 of 7
Sector (Software) 1 of 1
Type (Add-on Acquisition) 7 of 7
Country (Netherlands) 1 of 1
Year (2024) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-07-08 Igenomix

Valencia, Spain

Igenomix engages in women’s health and reproductive genetic testing services for IVF clinics. The Company support c. 90,000 couples per year with a global footprint of 19 laboratories covering +80 countries. Igenomix was founded in 2011 and headquartered in Valencia, Spain.

Buy €1.3B
Mergr

Product

Company

Legal